Influenza hemagglutinin protein head region (HA head, HA1 domain)

The **influenza hemagglutinin protein head region** is the globular, membrane-distal portion of the hemagglutinin (HA) glycoprotein (also called the HA1 subunit or receptor-binding domain) on the surface of influenza viruses[1][5][6]. It is responsible for binding to sialic acid-containing receptors on host cells, which is essential for viral attachment and entry[1][3][5]. The HA head is the immunodominant site, serving as the primary target for most neutralizing antibodies induced by natural infection or vaccination, but is also highly variable, enabling the virus to escape immune detection (antigenic drift)[5][6]. Its critical role in host cell recognition and as a dominant antigen makes it a major therapeutic and vaccine target[1][5][6]. The head region’s structure and antigenicity are central to current influenza vaccine design, serological assays, and antibody therapy development.

Other names

Hemagglutinin headHA1HA receptor-binding domainInfluenza HA head region

Neutralizing antibodies bind to the HA head, blocking viral attachment to the host cell sialic acid receptors, thus preventing viral entry[1][5][6]. Experimental antivirals may directly interfere with receptor binding or induce conformational changes in HA